Nyxoah
Mont-saint-guibert
About Nyxoah
Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $287.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:NYXH
- Website: nyxoah.com
- Phone: (322)612-1755
Industries & Categories
Health Care, Medical, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/nyxoah-51421 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.